EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H18N4O5 |
| Net Charge | 0 |
| Average Mass | 394.387 |
| Monoisotopic Mass | 394.12772 |
| SMILES | COc1ccc(CN2C(=O)NC(=O)C(=CNNC(=O)c3ccccc3)C2=O)cc1 |
| InChI | InChI=1S/C20H18N4O5/c1-29-15-9-7-13(8-10-15)12-24-19(27)16(18(26)22-20(24)28)11-21-23-17(25)14-5-3-2-4-6-14/h2-11,21H,12H2,1H3,(H,23,25)(H,22,26,28) |
| InChIKey | SOEBPBOJTDXZLN-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N'-[[1-[(4-methoxyphenyl)methyl]-2,4,6-trioxo-1,3-diazinan-5-ylidene]methyl]benzohydrazide (CHEBI:112204) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-23616 | LINCS |